| Entrepreneurial orientation as a basis for classification within a service industry: the case of retail pharmacy industry T Jambulingam, R Kathuria, WR Doucette Journal of operations management 23 (1), 23-42, 2005 | 323 | 2005 |
| Influence of franchisee selection criteria on outcomes desired by the franchisor T Jambulingam, JR Nevin Journal of Business Venturing 14 (4), 363-395, 1999 | 300 | 1999 |
| Technological innovations: a framework for communicating diffusion effects FJ Carter Jr, T Jambulingam, VK Gupta, N Melone Information & Management 38 (5), 277-287, 2001 | 187 | 2001 |
| Fairness-trust-loyalty relationship under varying conditions of supplier-buyer interdependence T Jambulingam, R Kathuria, JR Nevin Journal of Marketing Theory and Practice 19 (1), 39-56, 2011 | 117 | 2011 |
| How fairness garners loyalty in the pharmaceutical supply chain: Role of trust in the wholesaler‐pharmacy relationship T Jambulingam, R Kathuria, JR Nevin International journal of pharmaceutical and healthcare marketing 3 (4), 305-322, 2009 | 84 | 2009 |
| Pharmacy entrepreneurial orientation: antecedents and its effect on the provision of innovative pharmacy services WR Doucette, T Jambulingam Journal of Social and Administrative Pharmacy 16, 26-37, 1999 | 54 | 1999 |
| Entrepreneurial orientation: Its importance and performance as a driver of customer orientation and company effectiveness among retail pharmacies B Smith, T Jambulingam International Journal of Pharmaceutical and Healthcare Marketing 12 (2), 158-180, 2018 | 40 | 2018 |
| Estimating the value of internet marketing in the US pharmaceutical industry T Jambulingam, R Sharma Journal of Medical Marketing 10 (4), 332-343, 2010 | 16 | 2010 |
| Executive insights: International marketing managers: A comparison of Japanese, German, and US perceptions L Gorchels, T Jambulingam, TW Aurand Journal of International Marketing 7 (1), 97-105, 1999 | 15 | 1999 |
| Strategic alliance and acquisition performance: Impact of interfirm synergies and motives in the bio-pharmaceutical industry T Jambulingam, T Saxton Journal of Commercial Biotechnology 26 (4), 2021 | 11 | 2021 |
| Competitive analysis of CRM strategies using analytic hierarchy process T Jambulingam, MP Joshi, R Kathuria Management Dynamics, 1-22, 2018 | 10 | 2018 |
| The R&D Marketing Interface in Biopharma and MedTech. T Jambulingam Journal of Commercial Biotechnology 24 (4), 2019 | 9 | 2019 |
| Using a Rasch model to rank big pharmaceutical firms by financial performance T Jambulingam, C Schellhorn, R Sharma Journal of Commercial Biotechnology 22 (1), 2016 | 8 | 2016 |
| Wealth effects of the pharmaceutical industry‐physician interaction compliance guidelines on large pharmaceutical companies T Jambulingam, R Sharma, WQ Ghani International Journal of Pharmaceutical and Healthcare Marketing 3 (3), 210-235, 2009 | 7 | 2009 |
| Relationship between the Number of Firms and Generic Drug Price Competition T Jambulingam, DH Kreling Journal of Research in Pharmaceutical Economics 6 (3), 39-60, 1995 | 7 | 1995 |
| Internet marketing in healthcare: The case of generic drugs and the contagion effect W Ghani, T Jambulingam, R Sharma International Journal of Healthcare Management, 2019 | 5 | 2019 |
| The impact of transaction structure, interfirm synergies, and motives on performance of interfirm transactions in the pharmaceutical industry T Jambulingam, T Saxton Journal of Pharmaceutical Marketing & Management 15 (1), 73-95, 2002 | 5 | 2002 |
| Economic value added (EVA) as a measure of firm performance: An application to the pharmaceutical industry T Jambulingam Review of Quantitative Finance and Accounting 18 (1), 59-73, 2002 | 5 | 2002 |
| Identification of international marketing manager competencies: a tri-country study T Aurand, T Jambulingam, L Gorchels Available at SSRN 2289485, 2000 | 5 | 2000 |
| Path model of Wisconsin pharmacists’ hours supplied to the labor market DA Mott, T Jambulingam American journal of health-system pharmacy 54 (5), 558-563, 1997 | 5 | 1997 |
